Rapport Therapeutics (RAPP) Retained Earnings (2023 - 2026)
Rapport Therapeutics' (RAPP) quarterly Retained Earnings came in at -$255.1 million in Q1 2026, down 72.59% year-on-year from -$930.6 million in Q1 2025, and down 46818.86% on a QoQ basis from $546000.0 in Q4 2025.
Rapport Therapeutics (RAPP) Retained Earnings (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Retained Earnings data on file, last reported at -$255.1 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 72.59% year-over-year to -$255.1 million in Q1 2026; TTM through Mar 2026 was -$255.1 million, a 72.59% decrease from a year earlier, with the FY2025 full-year figure at $546000.0, up 204.6% from the prior year.
- Retained Earnings for Q1 2026 stood at -$255.1 million, down from $546000.0 in the prior quarter.
- Over the last five years, Retained Earnings for RAPP reached as high as $546000.0 in Q4 2025 and fell as low as -$255.1 million in Q1 2026.
- Historically, Retained Earnings has averaged -$93.3 million across 4 years, with a median of -$86.2 million in 2024.
- On a YoY basis, Retained Earnings climbed as much as 204.6% in 2025 and fell as far as 94.16% in 2025.
- Year by year, Retained Earnings stood at -$45.4 million in 2023, then surged by 98.85% to -$522000.0 in 2024, then jumped by 204.6% to $546000.0 in 2025, then tumbled by 46818.86% to -$255.1 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$255.1 million in Q1 2026, $546000.0 in Q4 2025, and -$201.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Rapport Therapeutics | 1.95 Bn | 1.95 Bn | - | -255.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -255.09 Mn |
| Dec 31, 2025 | 546,000.00 |
| Sep 30, 2025 | -201.47 Mn |
| Jun 30, 2025 | -76,000.00 |
| Mar 31, 2025 | -147.80 Mn |
| Dec 31, 2024 | -522,000.00 |
| Sep 30, 2024 | -103.77 Mn |
| Jun 30, 2024 | -86.20 Mn |
| Dec 31, 2023 | -45.44 Mn |